705
Views
28
CrossRef citations to date
0
Altmetric
Brief Communications

Successful management of olanzapine-induced anticholinergic agitation and delirium with a continuous intravenous infusion of physostigmine in a pediatric patient

, &
Pages 162-166 | Received 01 Nov 2012, Accepted 30 Jan 2013, Published online: 11 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kevin Baumgartner, Michelle Doering and & Michael E. Mullins. (2022) Dexmedetomidine in the treatment of toxicologic conditions: a systematic review and review of the toxicology investigators consortium database. Clinical Toxicology 60:12, pages 1356-1375.
Read now
George Sam Wang, Keith Baker, Patrick Ng, Gregory C. Janis, Jan Leonard, Rakesh D. Mistry & Kennon Heard. (2021) A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome. Clinical Toxicology 59:8, pages 698-704.
Read now

Articles from other publishers (26)

Beniamino Tripodi, Irene Matarese & Manuel Glauco Carbone. (2023) A Critical Review of the Psychomotor Agitation Treatment in Youth. Life 13:2, pages 293.
Crossref
Michaela Mayerová & Libor Ustohal. (2022) Some of the less frequent side effects of antipsychotics. Psychiatrie pro praxi 23:3, pages 144-149.
Crossref
Justin D. Spring, Brittany N. Goldstein, Mason Buster, Ahmed A. Mahmoud & Brandon Hamm. (2022) Physostigmine for Facilitation of Care in Clozapine-Associated Anticholinergic Delirium. Journal of Clinical Psychopharmacology 42:3, pages 329-331.
Crossref
Wilmarie Cidre Serrano & Jose Maldonado. (2021) The Use of Physostigmine in the Diagnosis and Treatment of Anticholinergic Toxicity After Olanzapine Overdose: Literature Review and Case Report. Journal of the Academy of Consultation-Liaison Psychiatry 62:3, pages 285-297.
Crossref
I Plaetinck, J Heerman, S Van De Velde, S Allaert & A.F. Kalmar. (2022) Anticholinergic symptoms in a patient with a bupropion overdose successfully managed with physostigmine: a case report. Acta Anaesthesiologica Belgica 72:1, pages 49-52.
Crossref
Kewal K. JainKewal K. Jain. 2021. Drug-induced Neurological Disorders. Drug-induced Neurological Disorders 233 264 .
A.F. Kalmar, I Plaetinck, J Heerman, S Van De Velde & S Allaert. (2022) Anticholinergic symptoms in a patient with a bupropion overdose successfully managed with physostigmine: a case report. Acta Anaesthesiologica Belgica 71:3, pages 137-140.
Crossref
Raghad Saadi & Kristin Bohnenberger. (2020) Physostigmine for Antimuscarinic Toxicity. Journal of Emergency Nursing 46:1, pages 126-128.
Crossref
Duygu Kınay & Ahmet Zihni Soyata. (2019) Biperiden-Induced Delirium In A Five-Years Old Child. Current Drug Safety 14:1, pages 48-50.
Crossref
George Sam Wang & Christopher Hoyte. (2018) Common Substances of Abuse. Pediatrics In Review 39:8, pages 403-414.
Crossref
José R. Maldonado. (2017) Acute Brain Failure. Critical Care Clinics 33:3, pages 461-519.
Crossref
Hui Wu, Jiangling Jiang, Jijun Wang, Xinyi Cao & Chunbo Li. (2017) Magnetic seizure therapy for people with schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Shanshan Wu, Zongwang Zhang, Tom Dening, Sai Zhao, Gillian Pinner, Jun Xia, Ailan Yu & Daogui Yang. (2017) Cholinesterase inhibitors for the treatment of delirium in non-ICU settings. Cochrane Database of Systematic Reviews.
Crossref
Philip Moore & Keith Burkhart. 2017. Critical Care Toxicology. Critical Care Toxicology 693 739 .
William J. Boroughf. 2017. Critical Care Toxicology. Critical Care Toxicology 2943 2955 .
Chung-Sik Oh, Ka Young Rhee, Tae-Gyoon Yoon, Nam-Sik Woo, Seung Wan Hong & Seong-Hyop Kim. (2016) Postoperative Delirium in Elderly Patients Undergoing Hip Fracture Surgery in the Sugammadex Era: A Retrospective Study. BioMed Research International 2016, pages 1-7.
Crossref
Philip Moore & Keith Burkhart. 2016. Critical Care Toxicology. Critical Care Toxicology 1 47 .
William J. Boroughf. 2016. Critical Care Toxicology. Critical Care Toxicology 1 14 .
Verónica O. Berríos, Nawal M. Boukli, Jose W. Rodriguez, Priscilla D. Negraes, Telma T. Schwindt, Cleber A. Trujillo, Sophia L. B. Oliveira, Luis A. Cubano, P. A. Ferchmin, Vesna A. Eterović, Henning Ulrich & Antonio H. Martins. (2015) Paraoxon and Pyridostigmine Interfere with Neural Stem Cell Differentiation. Neurochemical Research 40:10, pages 2091-2101.
Crossref
Elaine Perry, Urs Peter Mosimann & Daniel Collerton. 2015. The Neuroscience of Visual Hallucinations. The Neuroscience of Visual Hallucinations 321 341 .
José R. Maldonado. 2015. Handbook of Consultation-Liaison Psychiatry. Handbook of Consultation-Liaison Psychiatry 157 187 .
Jacqueline Flank, Lillian Sung, Christopher C. Dvorak, Wendy Spettigue & L. Lee Dupuis. (2014) The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis. Drug Safety 37:10, pages 791-804.
Crossref
Michelle A. Phillips, Nicole M. Acquisto, Rachel M. Gorodetsky & Timothy J. Wiegand. (2014) Use of a Physostigmine Continuous Infusion for the Treatment of Severe and Recurrent Antimuscarinic Toxicity in a Mixed Drug Overdose. Journal of Medical Toxicology 10:2, pages 205-209.
Crossref
Ali Mohammad Sabzghabaee, Ahmad Yaraghi, Elham Khalilidehkordi, Seyyed Mohammad Mahdy Mirhosseini, Elham Beheshtian & Nastaran Eizadi-Mood. (2014) The Outcome of Agitation in Poisoned Patients in an Iranian Tertiary Care University Hospital. Neurology Research International 2014, pages 1-5.
Crossref
J.P. Gray & S.D. Ray. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology 264 266 .
. (2013) Olanzapine overdose. Reactions Weekly 1453:1, pages 32-32.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.